For example patients and carers are often engaged to advise on:

• The design of our clinical trials, helping us ensure that our trials reflect the real experience of patients living with a particular condition.

• Informing us on the treatment outcomes that matter to patients and their carers so that we assess the efficacy and safety of our medicines in development in ways that are meaningful.

Health Economists help us understand the economic value of the medicines that we develop and advise us on which outcomes demonstrate the greatest impact of a medicine to society and the economy.

We believe that the disclosure of payments to members of the public is another important step forward in the work we are doing to ensure that the public can have confidence in the way our industry operates. Payments to members of the public are disclosed in an aggregated format to ensure that the privacy of patients, carers and other members of the public are appropriately protected.

Download our methodology note on members of the public reporting

Members of the public disclosure reports